Cystic Fibrosis Clinical Trials in Tucson, Arizona

4 studies are recruiting for cystic fibrosis in Tucson, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

    The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.

    Stage
    Not phased
    Ages
    3 to 18
    Site
    Tucson Cystic Fibrosis Center, Tucson, Arizona
    Locations
    33 in total
    Run by
    University of Washington, the Collaborative Health Studies Coordinating Center

    See if you can join NCT06654752 on ClinicalTrials.gov

  2. Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

    The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms in people with CF that needs me…

    Stage
    Phase 4
    Ages
    6 and older
    Site
    Tucson Cystic Fibrosis Center, Tucson, Arizona
    Locations
    60 in total
    Run by
    Chris Goss

    See if you can join NCT05548283 on ClinicalTrials.gov

  3. Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

    ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Arizona, Tucson, Arizona
    Locations
    13 in total
    Run by
    Arcturus Therapeutics, Inc.

    See if you can join NCT06747858 on ClinicalTrials.gov

  4. A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

    The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to in…

    Stage
    Not phased
    Ages
    12 and older
    Site
    Tucson Cystic Fibrosis Center, Tucson, Arizona
    Locations
    68 in total
    Run by
    Nicole Hamblett

    See if you can join NCT06504589 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.